Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Fukasawa

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2002
Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failureHiroshi Hayashi, Shinobu Kawakatsu, Kyota Watanabe, et al.
Chemical & Pharmaceutical Bulletin|August 2, 2008
Relation between drug-induced taste disorder and chelating behavior with zinc ion; statistical approach to the drug-induced taste disorder, part IITakashi Fukasawa, Takao Orii, Masayo Tanaka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 2, 2005
Statistical approach to drug-induced taste disorders based on zinc chelating abilityTakashi Fukasawa, Takao Orii, Masayo Tanaka, et al.
Therapeutic Drug Monitoring|September 24, 2004
Single oral dose pharmacokinetics of quazepam is influenced by CYP2C19 activityTakashi Fukasawa, Norio Yasui-Furukori, Toshiaki Aoshima, et al.
Journal of Clinical Pharmacology|November 15, 2003
Interaction study between fluvoxamine and quazepamHideto Kanda, Norio Yasui-Furukori, Takashi Fukasawa, et al.
Therapeutic Drug Monitoring|June 17, 2006
Rifampicin markedly decreases plasma concentration and hypnotic effect of brotizolamYukihiro Ujiie, Takashi Fukasawa, Norio Yasui-Furukori, et al.
Psychiatric Genetics|March 16, 2006
Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participantsHiroaki Shiraishi, Akihito Suzuki, Takashi Fukasawa, et al.
Depression and Anxiety|May 11, 2005
A three-factor model of the MADRS in major depressive disorderAkihito Suzuki, Toshiaki Aoshima, Takashi Fukasawa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 23, 2006
No association between the TPH A218C polymorphism and personality traits in Japanese healthy subjectsAkihito Suzuki, Takashi Fukasawa, Hiroaki Shiraishi, et al.
Therapeutic Drug Monitoring|June 17, 2006
Effects of caffeine on the kinetics of fluvoxamine and its major metabolite in plasma after a single oral dose of the drugTakashi Fukasawa, Norio Yasui-Furukori, Akihito Suzuki, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2002
Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failureHiroshi Hayashi, Shinobu Kawakatsu, Kyota Watanabe, et al.
Chemical & Pharmaceutical Bulletin|August 2, 2008
Relation between drug-induced taste disorder and chelating behavior with zinc ion; statistical approach to the drug-induced taste disorder, part IITakashi Fukasawa, Takao Orii, Masayo Tanaka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 2, 2005
Statistical approach to drug-induced taste disorders based on zinc chelating abilityTakashi Fukasawa, Takao Orii, Masayo Tanaka, et al.
Therapeutic Drug Monitoring|September 24, 2004
Single oral dose pharmacokinetics of quazepam is influenced by CYP2C19 activityTakashi Fukasawa, Norio Yasui-Furukori, Toshiaki Aoshima, et al.
Journal of Clinical Pharmacology|November 15, 2003
Interaction study between fluvoxamine and quazepamHideto Kanda, Norio Yasui-Furukori, Takashi Fukasawa, et al.
Therapeutic Drug Monitoring|June 17, 2006
Rifampicin markedly decreases plasma concentration and hypnotic effect of brotizolamYukihiro Ujiie, Takashi Fukasawa, Norio Yasui-Furukori, et al.
Psychiatric Genetics|March 16, 2006
Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participantsHiroaki Shiraishi, Akihito Suzuki, Takashi Fukasawa, et al.
Depression and Anxiety|May 11, 2005
A three-factor model of the MADRS in major depressive disorderAkihito Suzuki, Toshiaki Aoshima, Takashi Fukasawa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 23, 2006
No association between the TPH A218C polymorphism and personality traits in Japanese healthy subjectsAkihito Suzuki, Takashi Fukasawa, Hiroaki Shiraishi, et al.
Therapeutic Drug Monitoring|June 17, 2006
Effects of caffeine on the kinetics of fluvoxamine and its major metabolite in plasma after a single oral dose of the drugTakashi Fukasawa, Norio Yasui-Furukori, Akihito Suzuki, et al.
Pageof 3